Henry O. Gosebruch, President & CEO at Neumora Therapeutics, Inc. (NMRA), bought 15,000 shares at $12.62 ($189K) on 2023-09-19, disclosed to the SEC on 2023-09-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2022-03-01 | $2.2M | — | Filing → |
| ABBV | SELL | 2020-11-24 | $4.0M | — | Filing → |